🚀 VC round data is live in beta, check it out!
El.En. Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for El.En. Group and similar public comparables like AdaptHealth, Shanghai Haohai, Pulse Biosciences, Curiox Biosystems and more.
El.En. Group Overview
About El.En. Group
El.En. SpA is engaged in the research and development, manufacturing, distribution, and sales of laser systems. The company operates in two divisions: medical and industrial. In the medical division, the application of laser is used as a healing treatment for aesthetic, surgical, physiotherapy and dental. Industrial division develops solutions for laser material processing applications through cutting, marking, laser sources and restoration. The company generates the majority of its revenue from the medical division. Geographically, it derives maximum revenue from the Rest of the World.
Founded
1981
HQ
Employees
2.1K
Website
Financials (LTM)
EV
$1B
El.En. Group Financials
El.En. Group reported last 12-month revenue of $688M and EBITDA of $111M.
In the same LTM period, El.En. Group generated $111M in EBITDA and $60M in net income.
Revenue (LTM)
El.En. Group P&L
In the most recent fiscal year, El.En. Group reported revenue of $657M and EBITDA of $113M.
El.En. Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $688M | XXX | $657M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $277M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 42% | XXX | XXX | XXX |
| EBITDA | $111M | XXX | $113M | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $60M | XXX | $60M | XXX | XXX | XXX |
| Net Margin | 9% | XXX | 9% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
El.En. Group Stock Performance
El.En. Group has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
El.En. Group's stock price is $15.43.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | (0.2%) | XXX | XXX | XXX | $0.75 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEl.En. Group Valuation Multiples
El.En. Group trades at 1.6x EV/Revenue multiple, and 10.2x EV/EBITDA.
EV / Revenue (LTM)
El.En. Group Financial Valuation Multiples
As of March 7, 2026, El.En. Group has market cap of $1B and EV of $1B.
Equity research analysts estimate El.En. Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
El.En. Group has a P/E ratio of 20.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 10.2x | XXX | 10.0x | XXX | XXX | XXX |
| EV/EBIT | 12.1x | XXX | 13.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.1x | XXX | XXX | XXX |
| P/E | 20.6x | XXX | 20.6x | XXX | XXX | XXX |
| EV/FCF | 19.9x | XXX | 13.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified El.En. Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
El.En. Group Margins & Growth Rates
El.En. Group's revenue in the last 12 month grew by 7%.
El.En. Group's revenue per employee in the last FY averaged $0.3M.
El.En. Group's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
El.En. Group's rule of X is 33% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
El.En. Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | (3%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 33% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
El.En. Group Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AdaptHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Shanghai Haohai | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulse Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Curiox Biosystems | XXX | XXX | XXX | XXX | XXX | XXX |
| Shinva | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
El.En. Group M&A Activity
El.En. Group acquired XXX companies to date.
Last acquisition by El.En. Group was on XXXXXXXX, XXXXX. El.En. Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by El.En. Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEl.En. Group Investment Activity
El.En. Group invested in XXX companies to date.
El.En. Group made its latest investment on XXXXXXXX, XXXXX. El.En. Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by El.En. Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout El.En. Group
| When was El.En. Group founded? | El.En. Group was founded in 1981. |
| Where is El.En. Group headquartered? | El.En. Group is headquartered in Italy. |
| How many employees does El.En. Group have? | As of today, El.En. Group has over 2K employees. |
| Is El.En. Group publicly listed? | Yes, El.En. Group is a public company listed on Borsa Italiana. |
| What is the stock symbol of El.En. Group? | El.En. Group trades under ELN ticker. |
| When did El.En. Group go public? | El.En. Group went public in 2000. |
| Who are competitors of El.En. Group? | El.En. Group main competitors are AdaptHealth, Shanghai Haohai, Pulse Biosciences, Curiox Biosystems. |
| What is the current market cap of El.En. Group? | El.En. Group's current market cap is $1B. |
| What is the current revenue of El.En. Group? | El.En. Group's last 12 months revenue is $688M. |
| What is the current revenue growth of El.En. Group? | El.En. Group revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of El.En. Group? | Current revenue multiple of El.En. Group is 1.6x. |
| Is El.En. Group profitable? | Yes, El.En. Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of El.En. Group? | El.En. Group's last 12 months EBITDA is $111M. |
| What is El.En. Group's EBITDA margin? | El.En. Group's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of El.En. Group? | Current EBITDA multiple of El.En. Group is 10.2x. |
| What is the current FCF of El.En. Group? | El.En. Group's last 12 months FCF is $57M. |
| What is El.En. Group's FCF margin? | El.En. Group's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of El.En. Group? | Current FCF multiple of El.En. Group is 19.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.